Evidence map›Paper›PMID 42658278›Full record

ReviewPlant molecular biology2026

Molecular regulation of plant endoreduplication: core mechanisms and their upstream control.

Takashi Ishida

Abstract readReview
PubMed Publisher
In one paragraph

Review in Plant molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Takashi IshidaFaculty of Advanced Science and Technology, Kumamoto University, Kurokami 2-39-1, Kumamoto, 860-8555, Japan. ishida-takashi@kumamoto-u.ac.jp.ORCID http://orcid.org/0000-0001-5167-9971

Funding

Japan Society for the Promotion of Science 23K05803
6 · The paper itself

Abstract

Endoreduplication, or the endocycle, is a widespread developmental program in plants, in which cells repeatedly replicate their nuclear genome without cell division, leading to endopolyploidy. Unlike endomitosis or chemically induced polyploidization, this process arises from an intrinsic reconfiguration of the cell cycle machinery that uncouples G1/S progression from M-phase entry. A useful conceptual framework for this regulation is the "endocycle oscillator", a periodic control logic that supports repeated rounds of DNA replication while bypassing mitosis. Studies in animal systems, particularly Drosophila, have helped define this logic, whereas how far comparable principles apply in plants remains less clear. This review integrates current understanding of the plant endocycle, progressing from the operational logic of endocycle control to regulatory networks characterized in angiosperms. It specifically addresses how current findings in plants can be organized in terms of repeated S-phase entry and mitotic suppression. Available evidence points to important roles for licensing-related pathways in repeated genome duplication and for cyclin-CDKB complexes in the control of mitotic entry. Diverse upstream signals, such as light, phytohormones, and DNA damage responses, converge on this core machinery to modulate ploidy levels during organogenesis and stress adaptation. In this context, endoreduplication is increasingly recognized as a flexible mechanism that supports developmental plasticity. Identifying feedback loops that generate periodicity within the plant endocycle oscillator and advancing from static ploidy assessments to dynamic, system-level analyses will be essential for clarifying how plants deploy this cell cycle variant.

Indexed as

EndoreduplicationPlantsCell CycleDNA ReplicationGene Expression Regulation, PlantMitosisPolyploidyEndocycle oscillatorEndopolyploidyEndoreduplicationMitotic bypassPlant cell cycle control

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.